From a clinical perspective, how do you sequence therapies for patients with CTCL? What is the initial modality, and why, and when does ECP represent an evidence-based approach to treating CTCL? How many ECP treatments and at what frequency?

From a clinical perspective, how do you sequence therapies for patients with CTCL? What is the initial modality, and why, and when does ECP represent an evidence-based approach to treating CTCL? How many ECP treatments and at what frequency?

From a clinical perspective, how do you sequence therapies for patients with CTCL? What is the initial modality, and why, and when does ECP represent an evidence-based approach to treating CTCL? How many ECP treatments and at what frequency?


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Richard Edelson, MD

Richard Edelson, MD

Aaron B. and Marguerite Lerner Professor of Dermatology
Chair and Professor
Department of Dermatology
Yale School of Medicine